SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Alcohol-Related Disorders D019973 3 associated lipids
Lead Poisoning D007855 4 associated lipids
Urinary Incontinence D014549 4 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Dyspepsia D004415 5 associated lipids
Hypertension, Renovascular D006978 10 associated lipids
Amnesia D000647 12 associated lipids
Glucose Intolerance D018149 13 associated lipids
Angina, Unstable D000789 14 associated lipids
Brain Infarction D020520 17 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Zhang X et al. Puerarin Attenuates Cardiac Hypertrophy Partly Through Increasing Mir-15b/195 Expression and Suppressing Non-Canonical Transforming Growth Factor Beta (Tgfβ) Signal Pathway. 2016 Med. Sci. Monit. pmid:27145790
Xiong N et al. hVMAT2: A Target of Individualized Medication for Parkinson's Disease. 2016 Neurotherapeutics pmid:27137201
Wang Q et al. WITHDRAWN: Puerarin injection for unstable angina pectoris. 2016 Cochrane Database Syst Rev pmid:27136749
Wang ZK et al. Alleviation of Lead-Induced Apoptosis by Puerarin via Inhibiting Mitochondrial Permeability Transition Pore Opening in Primary Cultures of Rat Proximal Tubular Cells. 2016 Biol Trace Elem Res pmid:27116952
Yuan SY et al. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. 2016 Chin J Nat Med pmid:27114313
Cheng Y et al. Protective Effect of Puerarin Against Oxidative Stress Injury of Neural Cells and Related Mechanisms. 2016 Med. Sci. Monit. pmid:27074962
Saraswat G et al. Molecular cues to the anti-implantation effect of nano-puerarin in rats. 2016 Reproduction pmid:27026713
Xue Q et al. Lyophilized Powder of Catalpol and Puerarin Protects Neurovascular Unit from Stroke. 2016 Int. J. Biol. Sci. pmid:27019622
Zhao J et al. Plant Natural Product Puerarin Ameliorates Depressive Behaviors and Chronic Pain in Mice with Spared Nerve Injury (SNI). 2017 Mol. Neurobiol. pmid:27013468
Ma Y et al. Puerarin Attenuates Anoxia/Reoxygenation Injury Through Enhancing Bcl-2 Associated Athanogene 3 Expression, a Modulator of Apoptosis and Autophagy. 2016 Med. Sci. Monit. pmid:27011313
Luo X et al. Puerarin Exerts a Delayed Inhibitory Effect on the Proliferation of Cardiomyocytes Derived from Murine ES Cells via Slowing Progression through G2/M Phase. 2016 Cell. Physiol. Biochem. pmid:27008508
Hu Y et al. Inhibitory effect of puerarin on vascular smooth muscle cells proliferation induced by oxidised low-density lipoprotein via suppressing ERK 1/2 phosphorylation and PCNA expression. 2016 Pharmazie pmid:27004373
Qu H et al. Rapid lateral-flow immunoassay for the quantum dot-based detection of puerarin. 2016 Biosens Bioelectron pmid:26991602
Jiang QD and Li XP Effect of puerarin on the expression of NMU, NPY, and POMC genes in the hypothalamus. 2016 Genet. Mol. Res. pmid:26985919
Su HF et al. Absorptive interactions of concurrent oral administration of (+)-catechin and puerarin in rats and the underlying mechanisms. 2016 Acta Pharmacol. Sin. pmid:26972494
Xu X et al. Puerarin reduces apoptosis in rat hippocampal neurons culturea in high glucose medium by modulating the p38 mitogen activated protein kinase and c-Jun N-terminal kinase signaling pathways. 2016 J Tradit Chin Med pmid:26946623
Liu B et al. Puerarin for ischaemic stroke. 2016 Cochrane Database Syst Rev pmid:26891451
Hong XP et al. Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain. 2016 J. Alzheimers Dis. pmid:26890737
Li W et al. Puerarin Improves Diabetic Aorta Injury by Inhibiting NADPH Oxidase-Derived Oxidative Stress in STZ-Induced Diabetic Rats. 2016 J Diabetes Res pmid:26881260
Chang BY et al. Protective activity of kudzu (Pueraria thunbergiana) vine on chemically-induced hepatotoxicity: in vitro and in vivo studies. 2016 BMC Complement Altern Med pmid:26825303
Suthon S et al. Anti-osteoporotic effects of Pueraria candollei var. mirifica on bone mineral density and histomorphometry in estrogen-deficient rats. 2016 J Nat Med pmid:26815435
Yang L et al. Puerarin Protects Pancreatic β-Cells in Obese Diabetic Mice via Activation of GLP-1R Signaling. 2016 Mol. Endocrinol. pmid:26789107
Qiao L et al. A HPLC-MS/MS method for determination of 6'''-feruloylspinosin in rat plasma and tissues: Pharmacokinetics and tissue distribution study. 2016 J Pharm Biomed Anal pmid:26780157
Zhao YZ et al. Using PG-Liposome-Based System to Enhance Puerarin Liver-Targeted Therapy for Alcohol-Induced Liver Disease. 2016 AAPS PharmSciTech pmid:26753818
Huang FJ and Chan WH Apoptotic effects on maturation of mouse oocytes, fertilization and fetal development by puerarin. 2016 Drug Chem Toxicol pmid:26712108
Cheng G et al. Preparation and In Vitro/In Vivo Evaluation of Puerarin Solid Self-Microemulsifying Drug Delivery System by Spherical Crystallization Technique. 2016 AAPS PharmSciTech pmid:26694058
Liu X et al. Puerarin ameliorates cognitive deficits in streptozotocin-induced diabetic rats. 2016 Metab Brain Dis pmid:26686502
Liu CM et al. Puerarin protects mouse liver against nickel-induced oxidative stress and inflammation associated with the TLR4/p38/CREB pathway. 2016 Chem. Biol. Interact. pmid:26607348
Zhang H et al. Puerarin Inhibits oxLDL-Induced Macrophage Activation and Foam Cell Formation in Human THP1 Macrophage. 2015 Biomed Res Int pmid:26576421
Wang D et al. Automated On-Line Microdialysis Sampling Coupled with HPLC for Synchronous Determination of Puerarin in Subcutaneous Tissue and Plasma Following Topical Administration. 2015 Clin. Lab. pmid:26554250
Wang D et al. Evaluation of kudzu root extract-induced hepatotoxicity. 2015 J Ethnopharmacol pmid:26545459
Liu S et al. Puerarin attenuates severe burn-induced acute myocardial injury in rats. 2015 Burns pmid:26514700
Zhao SS et al. Puerarin attenuates learning and memory impairments and inhibits oxidative stress in STZ-induced SAD mice. 2015 Neurotoxicology pmid:26511841
Wu S et al. Study of the Biotransformation of Tongmai Formula by Human Intestinal Flora and Its Intestinal Permeability across the Caco-2 Cell Monolayer. 2015 Molecules pmid:26501241
Zhai Y et al. Preparation and Characterization of Puerarin-Loaded Lipid Nanocapsules. 2015 J Nanosci Nanotechnol pmid:26353476
Yin M et al. Puerarin Suppresses the Self-Renewal of Murine Embryonic Stem Cells by Inhibition of REST-MiR-21 Regulatory Pathway. 2015 Cell. Physiol. Biochem. pmid:26330232
Zhu X et al. Puerarin Protects Human Neuroblastoma SH-SY5Y Cells against Glutamate-Induced Oxidative Stress and Mitochondrial Dysfunction. 2016 J. Biochem. Mol. Toxicol. pmid:26277993
Zhang F et al. Puerarin attenuates smoke inhalation injury by regulation of Th1/Th2 expression and inhibition of Th17 cells in rats. 2015 Int. Immunopharmacol. pmid:26218281
Pan X et al. Effect of Puerarin on Expression of ICAM-1 and TNF-α in Kidneys of Diabetic Rats. 2015 Med. Sci. Monit. pmid:26201474
Haque Bhuiyan MM et al. The neuritogenic and synaptogenic effects of the ethanolic extract of radix Puerariae in cultured rat hippocampal neurons. 2015 J Ethnopharmacol pmid:26196403
Zhang J et al. Puerarin attenuates cognitive dysfunction and oxidative stress in vascular dementia rats induced by chronic ischemia. 2015 Int J Clin Exp Pathol pmid:26191159
Liu B et al. Puerarin prevents cardiac hypertrophy induced by pressure overload through activation of autophagy. 2015 Biochem. Biophys. Res. Commun. pmid:26188094
Gang C et al. Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways. 2015 J Pharm Pharm Sci pmid:26158288
Yu D et al. Puerarin attenuates glucocorticoid-induced apoptosis of hFOB1.19 cells through the JNK- and Akt-mediated mitochondrial apoptotic pathways. 2015 Int. J. Mol. Med. pmid:26101183
Yi Y et al. The construction of puerarin nanocrystals and its pharmacokinetic and in vivo-in vitro correlation (IVIVC) studies on beagle dog. 2015 Colloids Surf B Biointerfaces pmid:26099971
Cheng W et al. Puerarin improves cardiac function through regulation of energy metabolism in Streptozotocin-Nicotinamide induced diabetic mice after myocardial infarction. 2015 Biochem. Biophys. Res. Commun. pmid:26079885
Wenjun H et al. The Protective Effect of Puerarin on Myocardial Infarction Reperfusion Injury (MIRI): A Meta-Analysis of Randomized Studies in Rat Models. 2015 Med. Sci. Monit. pmid:26067875
Sun D et al. Simultaneous determination of acetylpuerarin and puerarin in rat plasma by liquid chromatography-tandem mass spectrometry: Application to a pharmacokinetic study following intravenous and oral administration. 2015 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:26021848
Zhao J et al. Botanical Drug Puerarin Attenuates 6-Hydroxydopamine (6-OHDA)-Induced Neurotoxicity via Upregulating Mitochondrial Enzyme Arginase-2. 2016 Mol. Neurobiol. pmid:25952544
Liu AC et al. Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats. 2015 Chin J Nat Med pmid:25908622